(Reuters) - The company said it had reacquired all rights to use its technology for products containing ibuprofen, following Wyeth's termination of a license agreement.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment